High-resolution NMR studies of apical membrane antigen 1 (AMA1), a target for antimalarial drug development (#105)
Apical membrane antigen 1 (AMA1) is a protein of the Plasmodium parasite that is involved in the formation of the moving junction during red blood cell invasion (1). Invasion inhibitory molecules like R1 peptide and anti-AMA1 antibodies target a conserved hydrophobic cleft on AMA1 and block the invasion process. Thus, AMA1 has become a target for drug development (2). Here we describe the application of solution NMR spectroscopy to study AMA1-small molecule interactions. Based on perturbations in specific chemical shifts in the NMR spectrum of AMA1, it is feasible to map the binding sites for ligand/small inhibitory molecules, facilitating the design of new drugs to treat malaria.
AMA1 is a high molecular mass (42 kDa) protein, making resonance assignments particularly challenging because of peak overlap. We have used different isotope labelling approaches (3, 4) and regular TROSY-based triple resonance NMR experiments to obtain residue-specific and sequential assignments, respectively. The results from chemical shift analysis of AMA1 and their importance in mapping the binding sites on AMA1 for small inhibitory molecules will be presented.
- Tonkin ML, et al. (2011) Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide. Science 333:463-467.
- MacRaild CA, Anders RF, Foley M, & Norton RS (2011) Apical membrane antigen 1 as an anti-malarial drug target. Curr. Top. Med. Chem. 11:2039-2047.
- Hiroaki H (2013) Recent applications of isotopic labeling for protein NMR in drug discovery. Expert Opin. Drug Discov. 8:523-536.
- Krishnarjuna B, Jaipuria G, Thakur A, D’Silva P, & Atreya HS (2011) Amino acid selective unlabelling for sequence specific resonance assignments in proteins. J. Biomol. NMR 49:39-51.